Strickland-Marmol Leah B, Brem Steven, Rojiani Amyn M, Rojiani Mumtaz V
James A. Haley Veteran's Hospital13000 Bruce B Downs Blvd, Mail Code 113, Tampa, FL 33612, USA.
Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania3400 Spruce Street, 3rd Floor Silverstein, Philadelphia, PA 19104, USA.
Am J Cancer Res. 2017 Apr 1;7(4):973-981. eCollection 2017.
The contributions of histologic features including microvascular proliferation to the determination of malignancy in oligodendrogliomas remain uncertain. We have retrospectively performed morphometric assessments in 20 tumors histologically classified as well-differentiated (WHO Grade II, n=8) or anaplastic (WHO Grade III, n=12) oligodendrogliomas (WDO or AO). Quantitative studies utilized image analysis of double immunolabeled vasculature with anti CD34 with VIP chromogen (purple) and proliferating nuclei with anti MIB-1, using DAB (brown). Mean values are reported from five fields for each of twenty cases. The total number of MIB-1 positive tumor nuclei was 10 fold higher in AO vs WDO. The area occupied by vessels was also markedly increased in AO vs WDO, as was the microvessel density. Proliferating endothelial cells i.e. those with MIB-1 positive nuclei in CD34 positive cells were significantly increased (4.6 vs 0.26 positive nuclei per unit tumor area, P≤0.001) in AO. While in most areas these changes were evident as typical microvascular proliferation, other areas showed thin walled vessels with increased MIB-1 positivity. VEGF was only assessed morphologically and showed positive staining of vasculature only, in WDO, while AO also showed immunoreactivity of vessels and multiple areas of tumor cells. These findings support a contributory role for vascular proliferation in assessing histologic grade. These findings also suggest that VEGF expression which is confined to blood vessels in lower grade tumors but eventually is expressed by tumor cells in higher grade oligodendrogliomas may be an important factor as the tumor progresses.
包括微血管增殖在内的组织学特征对少突胶质细胞瘤恶性程度判定的作用仍不明确。我们回顾性地对20例组织学分类为高分化(世界卫生组织二级,n = 8)或间变性(世界卫生组织三级,n = 12)少突胶质细胞瘤(WDO或AO)进行了形态学评估。定量研究采用图像分析,用抗CD34与VIP显色剂(紫色)双重免疫标记脉管系统,用抗MIB-1与DAB(棕色)标记增殖细胞核。报告了20例中每例5个视野的平均值。AO中MIB-1阳性肿瘤细胞核总数比WDO高10倍。与WDO相比,AO中脉管占据的面积以及微血管密度也显著增加。在AO中,增殖的内皮细胞,即CD34阳性细胞中MIB-1阳性细胞核的细胞显著增加(每单位肿瘤面积4.6个阳性细胞核对0.26个,P≤0.001)。虽然在大多数区域这些变化表现为典型的微血管增殖,但其他区域显示出MIB-1阳性增加的薄壁血管。仅对VEGF进行了形态学评估,在WDO中VEGF仅显示脉管系统呈阳性染色,而AO中脉管和多个肿瘤细胞区域也显示免疫反应性。这些发现支持血管增殖在评估组织学分级中起作用。这些发现还表明,VEGF表达在低级别肿瘤中局限于血管,但在高级别少突胶质细胞瘤中最终由肿瘤细胞表达,这可能是肿瘤进展过程中的一个重要因素。